Investors & Media
News
Sage Therapeutics to Host Sage FutureCast Webcast
Sage FutureCast will discuss the Company’s research and development strategy, and clinical progress in programs throughout the depression, neurology, and neuropsychiatry franchises including zuranolone, SAGE-324 and SAGE-718, respectively.
Webcast Information
A live webcast of the presentation can be accessed on the investor page of Sage's website at investor.sagerx.com.
A replay of the webcast will be available on Sage's website approximately two hours after the completion of the event and will be archived for up to 30 days.
About
View source version on businesswire.com: https://www.businesswire.com/news/home/20211129005132/en/
Investor Contact
315-382-3979
helen.rubinstein@sagerx.com
Media Contact
617-949-4289
maureen.suda@sagerx.com
Source: